340 related articles for article (PubMed ID: 30133565)
41. Cardiothoracic manifestations of neuroendocrine tumours.
Mandegaran R; David S; Screaton N
Br J Radiol; 2016; 89(1060):20150787. PubMed ID: 26781701
[TBL] [Abstract][Full Text] [Related]
42. Percutaneous balloon valvuloplasty in carcinoid pulmonary valve stenosis.
Rasmussen VG; Kanstrup HL; Nielsen-Kudsk JE
Catheter Cardiovasc Interv; 2016 Dec; 88(7):1174-1176. PubMed ID: 27976548
[TBL] [Abstract][Full Text] [Related]
43. The carcinoid syndrome: an unusual cause of valvular heart disease.
Godshall D
J Emerg Med; 2001 Jul; 21(1):21-5. PubMed ID: 11399383
[TBL] [Abstract][Full Text] [Related]
44. Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea.
Masab M; Saif MW
Cancer Chemother Pharmacol; 2017 Dec; 80(6):1055-1062. PubMed ID: 29051994
[TBL] [Abstract][Full Text] [Related]
45. Chest radiography in the carcinoid syndrome.
Thorvinger B; Lundstedt C; Mårtensson H
Acta Radiol; 1987; 28(1):49-51. PubMed ID: 2952141
[TBL] [Abstract][Full Text] [Related]
46. Systemic Treatment Options for Carcinoid Syndrome: A Systematic Review.
Wolin EM; Benson Iii AB
Oncology; 2019; 96(6):273-289. PubMed ID: 31018209
[TBL] [Abstract][Full Text] [Related]
47. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
[TBL] [Abstract][Full Text] [Related]
48. Cardiac metastasis of neuroendocrine tumor of the thymus diagnosed by cardiac magnetic resonance T1 mapping: a case report.
Zhang J; Zeng M
J Int Med Res; 2020 Jun; 48(6):300060520931678. PubMed ID: 32558603
[TBL] [Abstract][Full Text] [Related]
49. Metastatic carcinoid tumors and the malignant carcinoid syndrome.
Kvols LK; Reubi JC
Acta Oncol; 1993; 32(2):197-201. PubMed ID: 8323761
[TBL] [Abstract][Full Text] [Related]
50. Telotristat ethyl for the treatment of carcinoid syndrome diarrhea not controlled by somatostatin analogues.
Kasi PM
Drugs Today (Barc); 2018 Jul; 54(7):423-432. PubMed ID: 30090879
[TBL] [Abstract][Full Text] [Related]
51. A prospective study of the pathophysiology of carcinoid crisis.
Condron ME; Jameson NE; Limbach KE; Bingham AE; Sera VA; Anderson RB; Schenning KJ; Yockelson S; Harukuni I; Kahl EA; Dewey E; Pommier SJ; Pommier RF
Surgery; 2019 Jan; 165(1):158-165. PubMed ID: 30415870
[TBL] [Abstract][Full Text] [Related]
52. Carcinoid Heart Disease: a Review.
Laskaratos FM; Davar J; Toumpanakis C
Curr Oncol Rep; 2021 Mar; 23(4):48. PubMed ID: 33725214
[TBL] [Abstract][Full Text] [Related]
53. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: echocardiography.
Plöckinger U; Gustafsson B; Ivan D; Szpak W; Davar J; ;
Neuroendocrinology; 2009; 90(2):190-3. PubMed ID: 19713710
[No Abstract] [Full Text] [Related]
54. Use of healthcare REsources and associated COsts in controlled versus uncontrolled carcinoid SYndrome in patients with neuroendocrine tumours: the RECOSY study.
Custodio A; Jimenez-Fonseca P; Carmona-Bayonas A; Gomez MJ; Del Olmo-García MI; Lorenzo I; Díaz JÁ; Canal N; De la Cruz G; Villabona C
Clin Transl Oncol; 2021 Oct; 23(10):2046-2056. PubMed ID: 34109562
[TBL] [Abstract][Full Text] [Related]
55. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
de Herder WW
Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
[TBL] [Abstract][Full Text] [Related]
56. Carcinoid heart disease.
Bhattacharyya S; Davar J; Dreyfus G; Caplin ME
Circulation; 2007 Dec; 116(24):2860-5. PubMed ID: 18071089
[No Abstract] [Full Text] [Related]
57. Serotonin pathway in carcinoid syndrome: Clinical, diagnostic, prognostic and therapeutic implications.
Fanciulli G; Ruggeri RM; Grossrubatscher E; Calzo FL; Wood TD; Faggiano A; Isidori A; Colao A;
Rev Endocr Metab Disord; 2020 Dec; 21(4):599-612. PubMed ID: 32152781
[TBL] [Abstract][Full Text] [Related]
58. Telotristat ethyl: a new option for the management of carcinoid syndrome.
Lamarca A; Barriuso J; McNamara MG; Hubner RA; Valle JW
Expert Opin Pharmacother; 2016 Dec; 17(18):2487-2498. PubMed ID: 27817224
[TBL] [Abstract][Full Text] [Related]
59. [Pathological implications in the neuroendocrine gastrointestinal system].
Piette C; Polus M; Louis E
Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
[TBL] [Abstract][Full Text] [Related]
60. Inhibition of Peripheral Synthesis of Serotonin as a New Target in Neuroendocrine Tumors.
Molina-Cerrillo J; Alonso-Gordoa T; Martínez-Sáez O; Grande E
Oncologist; 2016 Jun; 21(6):701-7. PubMed ID: 27107003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
